{"id":"https://openalex.org/W120967079","doi":null,"title":"A multi-center, double-blind, randomized, parallel group study to evaluate the effects of two different doses of losartan on morbidity and mortality in Chinese patients with symptomatic heart failure intolerant of angiotensin converting enzyme inhibitor treatment.","display_name":"A multi-center, double-blind, randomized, parallel group study to evaluate the effects of two different doses of losartan on morbidity and mortality in Chinese patients with symptomatic heart failure intolerant of angiotensin converting enzyme inhibitor treatment.","alternate_titles":[],"publication_year":2012,"publication_date":"2012-11-01","ids":{"openalex":"https://openalex.org/W120967079","mag":"120967079","pmid":"https://pubmed.ncbi.nlm.nih.gov/23106890"},"language":"en","primary_location":{"id":"pmid:23106890","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23106890","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chinese medical journal","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W120967079"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088226639","display_name":"Dayi Hu","orcid":"https://orcid.org/0000-0001-9255-1907","observed_orcids":["https://orcid.org/0000-0001-9255-1907"]},"institutions":[{"id":"https://openalex.org/I4210124809","display_name":"Peking University People's Hospital","ror":"https://ror.org/035adwg89","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210124809"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Da-Yi Hu","raw_affiliation_strings":["Department of Cardiology, Peking University People's Hospital, Beijing 100044, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, Peking University People's Hospital, Beijing 100044, China","institution_ids":["https://openalex.org/I4210124809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089532723","display_name":"Jun Huang","orcid":"https://orcid.org/0000-0002-4680-5344","observed_orcids":["https://orcid.org/0000-0002-4680-5344"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jun Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112127452","display_name":"Naisheng Cai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nai-Sheng Cai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102119656","display_name":"Wen-ling Zhu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wen-Ling Zhu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088338925","display_name":"Yishi Li","orcid":"https://orcid.org/0009-0006-2852-3921","observed_orcids":["https://orcid.org/0009-0006-2852-3921","https://orcid.org/0000-0003-1694-7242"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yi-Shi Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033051531","display_name":"Rachid Massaad","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachid Massaad","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077955682","display_name":"Mary Elizabeth Hanson","orcid":"https://orcid.org/0000-0003-4785-7207","observed_orcids":["https://orcid.org/0000-0003-4785-7207"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mary E Hanson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5101709015","display_name":"Kenneth Dickstein","orcid":"https://orcid.org/0000-0002-8131-1729","observed_orcids":["https://orcid.org/0000-0002-8131-1729"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenneth Dickstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"125","issue":"21","first_page":"3868","last_page":"3874"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13381","display_name":"Heart rate and cardiovascular health","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":1.0},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.8259999752044678},{"id":"https://openalex.org/keywords/ace-inhibitor-intolerance","display_name":"ACE inhibitor intolerance","score":0.8730000257492065},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.6850000023841858},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.8539999723434448},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.9359999895095825},{"id":"https://openalex.org/keywords/heart-failure-hospitalization","display_name":"heart failure hospitalization","score":0.9599999785423279},{"id":"https://openalex.org/keywords/chinese-patients","display_name":"Chinese patients","score":0.8080000281333923}],"concepts":[{"id":"https://openalex.org/C2780288358","wikidata":"https://www.wikidata.org/wiki/Q410074","display_name":"Losartan","level":4,"score":0.9517456889152527},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8782472610473633},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.8747303485870361},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6959151029586792},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6809182167053223},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6069319248199463},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5586063861846924},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.5016520023345947},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.4973805248737335},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.42653828859329224},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4121081829071045},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.35448700189590454},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.1875910758972168},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.14822867512702942}],"mesh":[{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019808","descriptor_name":"Losartan","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019808","descriptor_name":"Losartan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:23106890","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23106890","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chinese medical journal","raw_type":"Journal Article"},{"id":"mag:120967079","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23106890","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2334264381","https://openalex.org/W2130315539","https://openalex.org/W2105138814","https://openalex.org/W7096969301","https://openalex.org/W2169518752","https://openalex.org/W2056720539","https://openalex.org/W7096630108","https://openalex.org/W2165926695","https://openalex.org/W2100082183"],"abstract_inverted_index":{"BACKGROUND:":[0],"There":[1,165],"have":[2],"been":[3],"no":[4,167],"mortality/morbidity":[5],"endpoint":[6,93],"studies":[7],"with":[8,33,62,75,178,201,221,232],"losartan":[9,26,54,84,134,144,223,227],"in":[10,30,132,142,173,189,230],"Chinese":[11,31,60,190],"heart":[12,34,64,105,155,219,234],"failure":[13,47,65,156,220,235],"patients.":[14],"The":[15,91,182],"objective":[16],"was":[17,39,94,115],"to":[18,83,123,195,238],"evaluate":[19],"the":[20,45,95,124,133,143,174,202,242,245],"effects":[21],"of":[22,44,50,73,99,176,184,212,244],"high-dose":[23],"vs.":[24,226],"low-dose":[25],"on":[27],"clinical":[28,250],"outcomes":[29],"subjects":[32,131,141,177,231],"failure.":[35,106],"METHODS:":[36],"This":[37],"study":[38,204],"a":[40,208],"post":[41,186],"hoc":[42,187],"analysis":[43,188],"Heart":[46,68],"Endpoint":[48],"evaluation":[49],"Angiotensin":[51],"II":[52],"Antagonist":[53],"(HEAAL)":[55],"trial":[56],"(n":[57],"=":[58],"545).":[59],"adults":[61],"symptomatic":[63,233],"(New":[66],"York":[67],"Association":[69],"(NYHA)":[70],"II-IV)":[71],"intolerant":[72],"treatment":[74,171],"angiotensin":[76],"converting":[77],"enzyme":[78],"(ACE)":[79],"inhibitors":[80],"were":[81,110,120,152,166,198],"randomized":[82],"150":[85,135,224],"mg":[86,89,136,146,225,229],"or":[87,102,151,216],"50":[88,145,228],"daily.":[90],"primary":[92],"composite":[96],"event":[97],"rate":[98],"all-cause":[100],"death":[101,215],"hospitalization":[103,217],"for":[104,154,218,248],"Safety":[107],"and":[108,138,236],"tolerability":[109],"assessed.":[111],"RESULTS:":[112],"Median":[113],"follow-up":[114],"4.8":[116],"years.":[117],"Baseline":[118],"characteristics":[119],"generally":[121,199],"similar":[122],"overall":[125],"HEAAL":[126],"cohort.":[127],"Overall,":[128],"120":[129],"(44.1%)":[130],"group":[137,147],"137":[139],"(50.2%)":[140],"died":[148],"(any":[149],"cause)":[150],"hospitalized":[153],"(hazard":[157],"ratio":[158],"(OR)":[159],"0.807,":[160],"95%CI":[161],"0.631":[162],"-":[163],"1.031).":[164],"notable":[168],"differences":[169],"between":[170],"groups":[172],"proportion":[175],"adverse":[179],"experiences.":[180],"CONCLUSION:":[181],"results":[183],"this":[185],"subjects,":[191],"although":[192],"not":[193],"powered":[194],"show":[196],"significance,":[197],"consistent":[200],"main":[203],"results,":[205],"which":[206],"demonstrated":[207],"significantly":[209],"reduced":[210],"risk":[211],"all":[213],"cause":[214],"daily":[222],"intolerance":[237],"ACE":[239],"inhibitors,":[240],"supporting":[241],"use":[243],"higher":[246],"dose":[247],"optimum":[249],"benefit.":[251]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W120967079","counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
